SEC CIK 1297709

Novartis Bioventures Ltd

Reported ownership across 6 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
ALTview stock →8,345,1452018-09-12
ARPOview stock →4,049,8042019-04-26
GRTXview stock →2,467,9612020-06-19
ALRNview stock →2,079,3942019-04-01
BCYCview stock →1,769,6412019-05-28
AKUSview stock →1,181,2582020-06-30

Position History — BCYC

Reported shares owned immediately after each Form 4 transaction, over time.

0589,8801,179,7611,769,6412019-052019-052019-052019-05

Recent Filings — BCYC

DateActivitySharesPriceOwned After
2019-05-28Conversion (derivative)636,3660
2019-05-28Option exercise (out-of-money) (derivative)71,4500
2019-05-28Conversion (derivative)893,1950
2019-05-28Open-market buy168,630$14.001,769,641
2019-05-28Conversion636,3661,601,011
2019-05-28Option exercise (out-of-money)71,450964,645
2019-05-28Conversion893,195893,195

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.